Sickle Cell Disease Patient Recruitment in New Jersey

TheraNovex connects clinical trial sponsors with pre-screened, eligible Sickle Cell Disease patients across New Jersey, including Newark, Jersey City, Paterson, and beyond.

Sickle cell disease patient recruitment for HbSS, HbSC, and gene therapy clinical trials.

Who qualifies: Patients with SCD (HbSS, HbSC, HbSβ⁰-thalassemia) aged 12+ with history of vaso-occlusive crises.

Recruitment challenges: Hemoglobin genotype confirmation and prior hydroxyurea treatment eligibility.

Our approach: Sickle cell disease center networks, patient advocacy partnerships, and genotype pre-screening.

Our recruitment network spans all major metropolitan areas in New Jersey, ensuring broad geographic coverage for your Sickle Cell Disease trial.